Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 280

The DOI matches its Crossref record.

Azathioprine in Behçet's syndrome. Effects on long‐term prognosis

Hamuryudan, Vedat, Özyazgan, Yilmaz, Hizli, Nail, Mat, Cem, Yurdakul, Sebahattin, Tüzün, Yalçin, Şlenocak, Mustafa, Yazici, Hasan·1997·Arthritis & Rheumatism

Abstract

Objective. To assess the effect of azathioprine (AZA) treatment on long‐term prognosis in Behçet's syndrome. Methods. Patients (all male) who took part in a double‐blind, placebo‐controlled trial of AZA a mean ± SD of 94 ± 10 months previously were reevaluated. Results. The emergence of blindness (log rank χ 2 = 5.6, P = 0.02) and a 2‐line drop in the visual acuity of the right eye (log rank χ 2 = 5.9, P = 0.015) occurred significantly more frequently among the patients originally allocated to the placebo group compared with patients who originally received AZA, despite posttrial treatment for patients in both groups when needed. There was also a trend toward more frequent occurrence of extraocular complications in the placebo group. The beneficial effect of AZA was especially pronounced among patients who had eye involvement of short duration prior to their entry into the trial. Conclusion. Early treatment with AZA tends to favorably affect the long‐term prognosis of Behçet's syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.1780400425

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 280

Metadata

Authors
Hamuryudan, V., Özyazgan, Y., Hizli, N., Mat, C., Yurdakul, S., Tüzün, Y., Şlenocak, M., & Yazici, H.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
1997-04
Volume
40
Issue
4
Pages
769-774
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2156195056
Cited by
280
References
0
FWCI
13.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Azathioprine in Behçet's syndrome. Effects on long‐term prognosis. https://app.cochat.ai/papers/10.1002/art.1780400425
The paper
Hamuryudan, V., Özyazgan, Y., Hizli, N., Mat, C., Yurdakul, S., Tüzün, Y., Şlenocak, M., & Yazici, H. (1997). Azathioprine in Behçet's syndrome. Effects on long‐term prognosis. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780400425

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.